MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
By D. Taylor, Ç. Gerçel-Taylor. Gynecologic Oncology, 2008
2,343 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/395af6c6f70bb121ed7a4758dc76deed28b6e561
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- C. Théry
- Raghu Kalluri
- T. Whiteside
- G. Raposo
- Suresh Mathivanan
- Richard J. Simpson
- Marina Colombo
- A. Llorente
In Molecular Biology
- C. Théry
- G. Raposo
- Suresh Mathivanan
- Richard J. Simpson
- Raghu Kalluri
- Marina Colombo
- X. Breakefield
- T. Whiteside
In Reproductive Medicine
- M. Michael
- Suresh Mathivanan
- Richard J. Simpson
- T. Whiteside
- R. Corteling
- I. Colao
- I. Wall
- Hamish W. King
Citations in the corpus
- Tumor-derived exosomes and their role in cancer progression (2016, background): “, miR-21, were found to be highly expresses in exosomes from plasma of patients with solid tumors such as glioblastoma, ovarian, breast and prostate carcinomas [118], and miR-21 expression levels correlated with the disease presence, progression and response to therapy [138, 143].”
- microRNA as Biomarkers and Diagnostics (2016, background): “Exosomal miRNAs have been detected in the peripheral blood and culture media of several cell lines (Valadi et al., 2007; Taylor and Gercel-Taylor, 2008) and might be useful for development of biomarkers associated with adenocarcinoma (Rabinowits et al., 2009).”
- Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. (2013, background): “For example, tumor-derived exosomes have been shown to contain either tumor antigens [51,59–61] or tumor-specific microRNAs [62].”
- Characterization of human plasma-derived exosomal RNAs by deep sequencing (2013, background): “It has been reported that exosomes from diseased individuals contained RNAs that were not found in healthy subjects [7,9].”
- Biological properties of extracellular vesicles and their physiological functions (2015, background): “However, sub-fractionations of EV subgroups may potentially be achievable by the application of forms of affinity chromatography, employing antibodies against known or suspected EV surface markers (28,29), or using ligands (e.”
- Influence of storage condition on exosome recovery (2016, neutral): “Taylor, D. D. and C. Gercel-Taylor (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.”